[HTML][HTML] Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression
Q Li, B Ren, Q Gui, J Zhao, M Wu, M Shen… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Hepatocellular carcinoma (HCC) is the fourth most common malignant tumor in
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
[PDF][PDF] Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression
Q Li, B Ren, Q Gui, J Zhao, M Wu, M Shen, D Li, D Li… - 2020 - cdn.amegroups.cn
Background: Hepatocellular carcinoma (HCC) is the fourth most common malignant tumor in
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
[HTML][HTML] Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression
Q Li, B Ren, Q Gui, J Zhao, M Wu… - Annals of …, 2020 - atm.amegroups.org
Background: Hepatocellular carcinoma (HCC) is the fourth most common malignant tumor in
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression
Q Li, B Ren, Q Gui, J Zhao, M Wu… - Annals of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Hepatocellular carcinoma (HCC) is the fourth most common malignant tumor in
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression.
Q Li, B Ren, Q Gui, J Zhao, M Wu, M Shen… - Annals of …, 2020 - europepmc.org
Background Hepatocellular carcinoma (HCC) is the fourth most common malignant tumor in
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
[引用][C] Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression
Q Li, B Ren, Q Gui, J Zhao, M Wu… - Annals of …, 2020 - atm.amegroups.org
Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via
downregulating MGMT expression - Li - Annals of Translational Medicine Have a website …
downregulating MGMT expression - Li - Annals of Translational Medicine Have a website …
Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression.
Q Li, B Ren, Q Gui, J Zhao, M Wu, M Shen… - Annals of …, 2020 - europepmc.org
Background Hepatocellular carcinoma (HCC) is the fourth most common malignant tumor in
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …